Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond H Kim

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 3, 2026
Multi-Platform Curation in the Development of ACMG/AMP Specifications for Von Hippel-Lindau (VHL) DiseaseDeborah I Ritter, Chansonette Badduke, Kurston Doonanco, et al.
Nature Cancer|February 19, 2026
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detectionYong Zeng, Dor D Abelman, Althaf Singhawansa, et al.
Clinical Genetics|August 2, 2019
Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patientsYasser Salama, Saleh Albanyan, Marta Szybowska, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 12, 2024
Opportunistic genomic screening has clinical utility: An interventional cohort studyChloe Mighton, Rita Kodida, Salma Shickh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 17, 2025
Opportunistic screening for broad range of medically relevant secondary findings: Laboratory benefits and burdensChloe Mighton, Emma Reble, Jordan Sam, et al.
Cancers|June 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and OpportunitiesMeghan J Walker, Kristina M Blackmore, Amy Chang, et al.
Cancer Discovery|January 4, 2023
Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNAIsidro Cortes-Ciriano, Christopher D Steele, Katherine Piculell, et al.
Journal of Medical Genetics|June 26, 2020
Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort studySalma Shickh, Mariana Gutierrez Salazar, Kathleen-Rose Zakoor, et al.
Genome Medicine|October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy L Stockley, Amit M Oza, Hal K Berman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 3, 2026
Multi-Platform Curation in the Development of ACMG/AMP Specifications for Von Hippel-Lindau (VHL) DiseaseDeborah I Ritter, Chansonette Badduke, Kurston Doonanco, et al.
Nature Cancer|February 19, 2026
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detectionYong Zeng, Dor D Abelman, Althaf Singhawansa, et al.
Clinical Genetics|August 2, 2019
Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patientsYasser Salama, Saleh Albanyan, Marta Szybowska, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 12, 2024
Opportunistic genomic screening has clinical utility: An interventional cohort studyChloe Mighton, Rita Kodida, Salma Shickh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 17, 2025
Opportunistic screening for broad range of medically relevant secondary findings: Laboratory benefits and burdensChloe Mighton, Emma Reble, Jordan Sam, et al.
Cancers|June 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and OpportunitiesMeghan J Walker, Kristina M Blackmore, Amy Chang, et al.
Cancer Discovery|January 4, 2023
Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNAIsidro Cortes-Ciriano, Christopher D Steele, Katherine Piculell, et al.
Journal of Medical Genetics|June 26, 2020
Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort studySalma Shickh, Mariana Gutierrez Salazar, Kathleen-Rose Zakoor, et al.
Genome Medicine|October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy L Stockley, Amit M Oza, Hal K Berman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Pageof 19